Superworth

Liquidia EPS LQDA

Diluted earnings per share by quarter and over the last twelve months, from 2017.

Last 12 months, to Jun 30, 2026
$1.39
Latest quarter, Q2 FY26
$0.74
Fiscal year 2025
−$0.81

Liquidia's earnings per share was $1.39 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was $0.74.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.81n/a
FY2024−$1.64n/a
FY2023−$1.20n/a
FY2022−$0.69n/a
FY2021−$0.70n/a
FY2020−$1.80n/a
FY2019−$2.61n/a
FY2018−$55.65n/a
FY2017−$54.08n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26$0.74n/a$1.39
Q1 FY26$0.52n/a$0.16
Q4 FY25$0.17n/a−$0.81
Q3 FY25−$0.04n/a−$1.44
Q2 FY25−$0.49n/a−$1.80
Q1 FY25−$0.45n/a−$1.69
Q4 FY24−$0.46n/a−$1.64
Q3 FY24−$0.40n/a−$1.60
Q2 FY24−$0.38n/a−$1.44
Q1 FY24−$0.40n/a−$1.42
Q4 FY23−$0.42n/a−$1.20
Q3 FY23−$0.24n/a−$0.88

Against its peers

Companies in Drug Manufacturers - General nearest Liquidia's size, closest first, today.

CompanyEPS, 12 monthsGrowth
LQDALiquidia$1.39
ARQTArcutis Biotherapeutics$0.22
OGNOrganon$0.77−71% a year
INDVIndivior Pharmaceuticals$2.78+227% a year
NRIXNurix Therapeutics$2.31
KNSAKiniksa Pharmaceuticals International$0.97+2325% a year
LGNDLigand Pharmaceuticals$9.40
PBHPrestige Consumer Healthcare$3.57−16% a year
AMRXAmneal Pharmaceuticals$0.49+4800% a year
HRMYHarmony Biosciences$3.09−0% a year
ALKSAlkermes plc.$0.38−82% a year
Peer median$1.64

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Liquidia

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.